Aditxt, Inc. Accounts Payable and Other Accrued Liabilities, Current
Aditxt, Inc. (ADTX) had Accounts Payable and Other Accrued Liabilities, Current of $3.67 thousand as of 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2021-03-25
- 2020-09-30: Accounts Payable and Other Accrued Liabilities, Current $3.67K.
- 2020-06-30: Accounts Payable and Other Accrued Liabilities, Current $1.22M.
- 2019-12-31: Accounts Payable and Other Accrued Liabilities, Current $962.65K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2020-09-30 | $3.67K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.22M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $962.65K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |